| Code | 2067E | ||||||||||
| MA number | 36/0257/22-S | ||||||||||
| Product Form: | sol por 1x200 ml/300 mg (fľ.skl.hnedá) | ||||||||||
| MA Status: | R - Valid Marketing Authorisation | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| MAH, country: | MEDOCHEMIE Ltd., Cyprus | ||||||||||
| Therapeutic Class: | 36 - ANTITUSSICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 24 | ||||||||||
| Container: | brown glass bottle | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product not subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 28.09.2022 |
| Validity: | 28.09.2027 |
| Pediatric indication: | Yes |
| Pediatric posology: | Yes |
| Pediatric contraindication: | Yes |
| PIL: |
PIL_Parmenol 1,5 mg_ml perorálny roztok_09_2022.pdf
|
| SPC: |
SPC_Parmenol 1,5 mg_ml perorálny roztok_09_2022.pdf
|
| Safety feature | No |
| Data update: | 29.09.2022 |
